Wuhan YZY Biopharma Co., Ltd.
2496 · HKEX
Public Market Listing
2496HKEX
Live quotes, historical charts, and market capitalization for Wuhan YZY Biopharma Co., Ltd. are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
Quarterly & interim (1)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-H1 | $5.1M | — | — | $4.1M | report ↗ |
Wuhan YZY Biopharma Co., Ltd. reported revenue of $5.13M and a net loss of $8.12M for H1 2025.
Figures only: this period's report disclosed no narrative text
Annual history (1 year)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-FY | $9.3M | — | $14M | $3.0M | report ↗ |